Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations. - Wikidata - wikimedia - TriplyDB

Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.

Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.

http://www.wikidata.org/entity/Q37521050

about

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B New targets in the search for preventive and therapeutic agents for botulism.An internal standard approach for homogeneous TR-FRET immunoassays facilitates the detection of bacteria, biomarkers, and toxins in complex matrices.The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.A Novel Rabbit Spirometry Model of Type E Botulism and its Use for the Evaluation of Post-symptom Antitoxin Efficacy.A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

P2860

Q26863621-6855EE87-457F-4732-8D81-AB0419CB7BC5 Q33845127-F0651144-BE47-4EDA-A6D4-787B1C15A3A2 Q35779652-3AF24026-7B99-4CB5-916F-803916B68B06 Q38236640-93C3D44B-910E-4F91-8F75-23D18FED9390 Q40655178-D6B4689D-5501-4630-A6A3-09C1EB728C4C Q45235847-D0A9AB2D-C657-4289-BDF6-1DB834AA7710 Q50044361-B1D925B6-CC9A-4DFA-90C9-955E3FB312A0 Q52679598-E05C64FE-5B0D-43D5-B5C0-EA50A232F7FE Q59127632-A6EF03A7-885C-439A-92F8-6050026B74AB

P2860

Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.

http://www.wikidata.org/entity/Q37521050

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluating the synergistic neu ...... oclonal antibody preparations.

@en

Evaluating the synergistic neu ...... oclonal antibody preparations.

@nl

type

label

Evaluating the synergistic neu ...... oclonal antibody preparations.

@en

Evaluating the synergistic neu ...... oclonal antibody preparations.

@nl

prefLabel

Evaluating the synergistic neu ...... oclonal antibody preparations.

@en

Evaluating the synergistic neu ...... oclonal antibody preparations.

@nl

P1433

Q37521050-B1587395-FE73-4D6C-89DB-CE5C6A5B8D6C

P1476

Q37521050-1396BEDE-DD9A-457B-B564-246030C0AE33

P2093

Q37521050-1E90DCC4-8A34-4A26-96C5-9ACAB5EC1287

Q37521050-419EA525-D3B1-4D4A-AC23-04A5A853AAE4

Q37521050-48F60236-3414-4075-90CB-38369DBF3539

Q37521050-5035877B-5FB8-44DA-90DD-12DFBD2849DA

Q37521050-83E687F2-03DB-402B-AED2-D40BB837293B

Q37521050-8BF3420F-FE60-4547-9E01-B5120660FB4B

Q37521050-9109C3AA-3B89-4706-BE00-3B595F513AC0

Q37521050-C14E69F2-83F9-454A-93CE-FF979C9A1EEA

P2860

Q37521050-0464E46A-10AF-4355-9D41-B6A6D300DA3F

Q37521050-05C60D3B-A43B-4259-9E5B-92804EAE538D

Q37521050-09333951-4951-4846-A1BD-FF2BE2890EA8

Q37521050-0E5C7F26-71C2-41B0-A8DD-B1271EE9B8ED

Q37521050-1438BB8A-6E63-4FA6-A15E-FFFE2359114F

Q37521050-1B430325-A9B4-42D8-ABB6-CF751C3D6722

Q37521050-1FDEEA77-FFD3-46E5-8765-535139A617F0

Q37521050-26782DAC-4665-4944-A2DC-10C7476CAF7B

Q37521050-28DA6931-CB9C-4C86-8E8B-8189CFE35D6F

Q37521050-33B3223E-2178-4A6E-A42B-0BBC7BCEC2F6

P304

Q37521050-C6E56517-A1FB-460A-8D3D-D33C678F0E13

P31

Q37521050-9F7A130C-2E86-4118-8BDD-C39BB46F2CCD

P356

Q37521050-F2010832-3147-40B5-B9B4-63F12FE350F8

P407

Q37521050-72719185-9920-42BB-8AFD-7566C5660B49

P433

Q37521050-5FEB27C7-1069-4F2B-A580-DC8449AF293B

P478

Q37521050-EAA59262-9B9C-416F-B909-14F3024B15A7

P577

Q37521050-58B5A794-0DC9-42A8-AFA5-2E9A7E982EE0

P5875

Q37521050-C52682A6-1B83-47FB-A193-2A1555E8A454

P698

Q37521050-9E019A7A-2ECA-4238-B996-24CDACC89C7C

P921

Q37521050-262D7702-ADAA-4E3D-9FFC-2C9BB3923011

P932

Q37521050-D547010F-1382-4F04-B5E5-E24A564A996E

P356

JOURNAL.PONE.0087089

P1433

P1476

Evaluating the synergistic neu ...... oclonal antibody preparations.

@en

P2093

Ada Barnea

http://www.w3.org/2001/XMLSchema#string

Adi Keren

http://www.w3.org/2001/XMLSchema#string

Alon Ben David

http://www.w3.org/2001/XMLSchema#string

Bat-El Lachmi

http://www.w3.org/2001/XMLSchema#string

Eran Diamant

http://www.w3.org/2001/XMLSchema#string

Hadar Marcus

http://www.w3.org/2001/XMLSchema#string

Ran Zichel

http://www.w3.org/2001/XMLSchema#string

Shoshana Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

Laboratory diagnostics of botulism

Bacterial toxins: a table of lethal amounts

Continuous cultures of fused cells secreting antibody of predefined specificity

Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A

Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.

Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins.

Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

P304

e87089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0087089

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259961110

http://www.w3.org/2001/XMLSchema#string

P698

24475231

http://www.w3.org/2001/XMLSchema#string

P921

P932

3903612

http://www.w3.org/2001/XMLSchema#string